Helios raises $2.3M

Helios announced a Seed round of $2.3M on 18 November 2026. The company operates in HealthTech and is based in United States. It was founded by Omar Abudayyeh, Co-founder. Announced yesterday.

Raised
$2.3M
Stage
Seed
Industry
HealthTech
Country
United States

Founder

Omar Abudayyeh
Co-founder, Helios
LinkedIn not availablemyhelios.com

Outreach angles

  • -Omar Abudayyeh conducted pioneering CRISPR diagnostics research at Harvard and MIT with co-founder Jonathan Gootenberg.
  • -Abudayyeh helped establish Sherlock Biosciences, which developed the first FDA-authorised CRISPR-based diagnostic test.
  • -Helios came out of stealth in Boston with a waitlist for an at-home test measuring more than 1,000 blood proteins.

Signals

SeedYC BackedHealthcareB2CSecond-Time FounderProduct Launch

Round details

Company: Helios
Domain: myhelios.com
Amount: $2.3M
Stage: Seed
Industry: HealthTech
Country: United States
Announced: 18 November 2026
Source: announcement

Other HealthTech raises

Recently funded in United States